Cargando…
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
The coronavirus SARS-CoV-2 is the causative agent of the ongoing severe acute respiratory disease pandemic COVID-19. Tissue and cellular tropism is one key to understanding the pathogenesis of SARS-CoV-2. We investigate the expression and subcellular localization of the SARS-CoV-2 receptor, angioten...
Autores principales: | Lee, Ivan T., Nakayama, Tsuguhisa, Wu, Chien-Ting, Goltsev, Yury, Jiang, Sizun, Gall, Phillip A., Liao, Chun-Kang, Shih, Liang-Chun, Schürch, Christian M., McIlwain, David R., Chu, Pauline, Borchard, Nicole A., Zarabanda, David, Dholakia, Sachi S., Yang, Angela, Kim, Dayoung, Chen, Han, Kanie, Tomoharu, Lin, Chia-Der, Tsai, Ming-Hsui, Phillips, Katie M., Kim, Raymond, Overdevest, Jonathan B., Tyler, Matthew A., Yan, Carol H., Lin, Chih-Feng, Lin, Yi-Tsen, Bau, Da-Tian, Tsay, Gregory J., Patel, Zara M., Tsou, Yung-An, Tzankov, Alexandar, Matter, Matthias S., Tai, Chih-Jaan, Yeh, Te-Huei, Hwang, Peter H., Nolan, Garry P., Nayak, Jayakar V., Jackson, Peter K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595232/ https://www.ncbi.nlm.nih.gov/pubmed/33116139 http://dx.doi.org/10.1038/s41467-020-19145-6 |
Ejemplares similares
-
Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers
por: Lee, Ivan T., et al.
Publicado: (2020) -
SARS-CoV-2 entry factors are expressed in nasal, ocular, and oral tissues: implications for COVID-19 prophylaxes/therapeutics
por: Lee, Ivan, et al.
Publicado: (2021) -
Determinants of SARS-CoV-2 entry and replication in airway mucosal tissue and susceptibility in smokers
por: Nakayama, Tsuguhisa, et al.
Publicado: (2021) -
Controversy regarding ACE inhibitors / ARBs in COVID-19
por: Soria Arcos, Federico, et al.
Publicado: (2020) -
ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022)